Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C

INTRODUCTION: Hepatitis C virus (HCV) infection is one of the principle causes of chronic liver disease. Successful treatment significantly decreases the risk of hepatic morbidity and mortality. Current standard of care achieves sustained virologic response (SVR) rates of 40–80%; however, the HCV th...

Descripción completa

Detalles Bibliográficos
Autores principales: McEwan, Phil, Ward, Thomas, Bennett, Hayley, Kalsekar, Anupama, Webster, Samantha, Brenner, Michael, Yuan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311930/
https://www.ncbi.nlm.nih.gov/pubmed/25635922
http://dx.doi.org/10.1371/journal.pone.0117334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311930/
https://www.ncbi.nlm.nih.gov/pubmed/25635922
http://dx.doi.org/10.1371/journal.pone.0117334

Ejemplares similares